Autoimmune disease drugs

These companies develop drugs that calm the immune system in diseases like lupus, rheumatoid arthritis and vasculitis.
+16.4%
over 3 months · S&P 500 −2.1%

Key indicators

Health
50 / 100
Fragile
Solid
Price
P/E 25
Cheap
Expensive
Up over 1 year
30 of 46
Wallets over 90 days
1 / 2 buys / sells
Buys
Sells
Health and price: against the other tags.

The 52 companies

LLY
+22.0%
JNJ
+9.4%
ABBV
+17.9%
Size: weight in the tag. Color: move over the period.
See all companies
L
Eli Lilly
LLY
51.6%
+22.0%
J
Johnson & Johnson
JNJ
25.5%
+9.4%
A
AbbVie
ABBV
20.0%
+17.9%
K
Kymera Therapeutics
KYMR
0.4%
+5.1%
S
Spyre Therapeutics
SYRE
0.4%
−0.6%
T
TG Therapeutics
TGTX
0.4%
+30.9%
I
Immunovant
IMVT
0.3%
−21.8%
O
Oruka Therapeutics
ORKA
0.3%
−6.5%
D
Dianthus Therapeutics
DNTH
0.2%
−20.1%
V
Viridian Therapeutics
VRDN
0.1%
+33.7%
X
Xencor
XNCR
0.1%
+60.4%
C
Celldex Therapeutics
CLDX
<0.1%
−31.2%
T
First Tracks Biotherapeutics
TRAX
<0.1%
+8.0%
Z
Zenas BioPharma
ZBIO
<0.1%
−8.2%
N
Nektar Therapeutics
NKTR
<0.1%
−48.7%
V
Vor Biopharma
VOR
<0.1%
−15.6%
J
Jade Biosciences
JBIO
<0.1%
−31.2%
O
Odyssey Therapeutics
ODTX
<0.1%
−8.2%
C
Corvus Pharmaceuticals
CRVS
<0.1%
−28.6%
G
Monte Rosa Therapeutics
GLUE
<0.1%
−39.1%
A
Alumis
ALMS
<0.1%
−78.0%
C
Cullinan Therapeutics
CGEM
<0.1%
−50.1%
A
Attovia Therapeutics
ATTO
<0.1%
−33.4%
C
Climb Bio
CLYM
<0.1%
−40.6%
A
Aclaris Therapeutics
ACRS
<0.1%
−33.8%
S
Shattuck Labs
STTK
<0.1%
−37.1%
A
Avalo Therapeutics
AVTX
<0.1%
−61.1%
C
Cabaletta Bio
CABA
<0.1%
−55.7%
E
Enanta Pharmaceuticals
ENTA
<0.1%
−14.3%
K
Kyverna Therapeutics
KYTX
<0.1%
−43.6%
E
Evommune
EVMN
<0.1%
−46.5%
Q
Q32 Bio
QTTB
<0.1%
−45.4%
A
Artiva Biotherapeutics
ARTV
<0.1%
−65.8%
P
Palisade Bio
PALI
<0.1%
−47.9%
Y
Yarrow Bioscience
YARW
<0.1%
−56.4%
F
Fate Therapeutics
FATE
<0.1%
−51.1%
Z
Zura Bio
ZURA
<0.1%
−78.2%
C
Cue Biopharma
CUE
<0.1%
−41.7%
A
Adicet Bio
ACET
<0.1%
−68.2%
A
Abivax
ABVX
−27.5%
A
argenx
ARGX
−2.8%
A
Aurinia Pharmaceuticals
AUPH
+2.9%
A
Autolus Therapeutics
AUTL
−48.7%
B
Bambusa Therapeutics
BBTX
E
Electra Therapeutics
ETRA
L
Lakefront Biotherapeutics
LKFT
+23.5%
L
Lycia Therapeutics
LYCA
M
Mesoblast
MESO
−22.0%
M
MoonLake Immunotherapeutics
MLTX
−23.5%
N
Novartis
NVS
+5.6%
R
Roche Holdings
RHHBY
0.0%
R
Roivant Sciences
ROIV
+9.1%